Holzer & Holzer, LLC has issued a reminder to shareholders of Vistagen Therapeutics, Inc. (VTGN) regarding the approaching March 16, 2026 deadline to file for lead plaintiff status in an ongoing securities class action lawsuit. The litigation alleges that the company made false or misleading statements to investors, or failed to disclose material risks that could have affected investment decisions during a specified period.
Investors who experienced financial losses on their VTGN holdings during the relevant timeframe are eligible to participate in the class action. Lead plaintiff designation carries the responsibility of representing all class members and working with counsel throughout the litigation process. The firm is encouraging affected shareholders to contact its office to understand their rights and explore potential recovery options.
This action is one of several securities class actions currently pending against pharmaceutical and technology companies, with lead plaintiff deadlines varying by case. Investors should note the specific deadline applicable to their holdings and consult with legal counsel to determine eligibility and next steps in the litigation process.